PPBT Purple Biotech Ltd.: Nilai perusahaan marang volume dodolan

Simbol resmi perusahaan purple-biotech.com (PPBT)

The valuation of Purple Biotech (PPBT) currently depends solely on trial results, as the company lacks pricing power. The company's price-to-sales ratio reflects the current trend, while 0.00 determines the latest valuation metric. Growth prospects are based on patents promising global market capture, while robotic AI screening automates the development of new targeted drugs.

Purple Biotech Ltd. (PPBT) - Multiplikator EV/Sales saka 23.11.2025 nganti 20.11.2026

Purple Biotech Corp - rincian analitis lan metrik utama (PPBT)

- data kapitalisasi saham perusahaan:
Pambiji fundamental perusahaan:PPBT (purple-biotech.com)
Sampel barang Purple Biotech Ltd

To identify fundamental support for an asset, it is essential to analyze changes in the EV/Sales multiple, which compares the total enterprise value to revenue, excluding the impact of debt to detect market overheating. Given the high clinical risks and constant capital dilution at Purple Biotech (PPBT), this indicator is critical, as it reveals the extent of the gap between the valuation of R&D potential and actual cash flows.

Analisis pesaing

Rasio nilai perusahaan marang dodolan BeiGene Ltd (ONC)|Halozyme Corp (HALO) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Revolution Medicines Inc (RVMD)|Rasio nilai perusahaan marang pendapatan Ascentage Pharma Group|Rasio nilai perusahaan marang pendapatan CGON (CG Oncology Corp)|Rasio nilai perusahaan marang pendapatan UroGen Pharma (URGN)|Multiplikator EV/Sales Bicara Therapeutics (BCAX)|Multiplikator EV/Sales PSNL (personalis.com)|Nilai bisnis marang pendapatan ERAS|DCTH: Nilai perusahaan marang pendapatan|YmAbs - Koefisien nilai perusahaan marang pendapatan|aurabiosciences.com (AURA) - Rasio nilai perusahaan marang pendapatan|Candel Therapeutics Inc. - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Accuray Inc.|Multiplikator nilai perusahaan marang pendapatan SELLAS Life Sciences Group SLS|Multiplikator EV/Sales ACTU|CTOR - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales HURA (TuHURA Biosciences, Inc.)|Nilai bisnis marang pendapatan TARA|FATE: Nilai perusahaan marang pendapatan|WHWK (aadibio.com) - Rasio nilai perusahaan marang pendapatan|TCRX (TScan Therapeutics, Inc.) - Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Champions Oncology Corp (CSBR)|XBIT (XBiotech Inc.) - Multiplikator EV/Sales|CVM (CEL-SCI Corporation) - Koefisien nilai perusahaan marang pendapatan|Multiplikator EV/Sales OSTX|Multiplikator EV/Sales Radiopharm Theranostics Ltd (RADX)|Multiplikator EV/Sales ARTV (Artiva Biotherapeutics)|Multiplikator EV/Sales Adlai Nortye Ltd. ANL|Veru Inc - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Tempest Therapeutics TPST|XLO: Multiplikator EV/Sales|Enochian BioSciences (RENB) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan MURA|Kairos Pharma Ltd - Nilai perusahaan marang volume dodolan|Multiplikator EV/Sales OKUR|CytoMed Therapeutics Limited (GDTC) - Rasio nilai perusahaan marang dodolan|Multiplikator EV/Sales CRIS (Curis, Inc.)|APLM: Rasio nilai perusahaan marang pendapatan|Tharimmune Corporation - Multiplikator EV/Sales|ADVB: Rasio nilai perusahaan marang pendapatan|GNPX: Multiplikator EV/Sales|CLDI (Calidi Biotherapeutics Inc.) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Sunshine Biopharma, Inc.|Multiplikator EV/Sales xeneticbio.com|Rasio nilai perusahaan marang pendapatan Salarius (SLRX)|Multiplikator EV/Sales American Oncology Network Inc (AONC)|Multiplikator EV/Sales BGNE (BeiGene Ltd.)|Koefisien nilai perusahaan marang pendapatan CKPT (Checkpoint Therapeutics)|ELEV - Rasio nilai perusahaan marang pendapatan|ICAD (iCAD Inc.) - Rasio nilai perusahaan marang pendapatan|Ikena (IKNA) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan Notable Labs, Ltd.|Rasio nilai perusahaan marang pendapatan viracta.com|MOR: Nilai bisnis marang pendapatan|Multiplikator EV/Sales NAYA|Ascentage Pharma - Rasio nilai perusahaan marang pendapatan